Welcome to LookChem.com Sign In|Join Free

CAS

  • or

128540-39-6

Post Buying Request

128540-39-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

128540-39-6 Usage

Description

(4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)methanamine is a complex organic chemical compound that features a phenyl ring connected to a methanamine group. (4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)methanamine also incorporates a 4-methylpiperazin-1-yl group and an ethoxy bridge, which may contribute to its potential pharmacological properties. It is a promising candidate for medicinal chemistry research aimed at developing new drugs.

Uses

Used in Pharmaceutical Research:
(4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)methanamine is used as a chemical entity in pharmaceutical research for its potential to be developed into new drugs. Its unique structure suggests it may have applications in modulating neurotransmitters, which could be beneficial for treating various central nervous system disorders.
Used in Neurotransmitter Modulation:
In the field of medicinal chemistry, (4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)methanamine is used as a neurotransmitter modulator. Its structure allows it to potentially interact with neurotransmitter systems in the brain, which could be useful in the development of treatments for neurological conditions.
Used in Anti-inflammatory Agents:
(4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)methanamine may also be used as a potential anti-inflammatory agent. Given its complex structure, it could have effects on inflammatory pathways, which would require further research to explore its full potential in this area.
Used in Central Nervous System Disorders Treatment:
In the medical field, (4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)methanamine is considered for use in the treatment of certain central nervous system disorders. Its potential to modulate neurotransmitters and possibly exhibit anti-inflammatory properties makes it a candidate for further research into its therapeutic effects on such conditions.
Further research is necessary to fully understand the potential applications and effects of (4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)methanamine, as its complex structure and potential interactions with biological systems warrant in-depth study.

Check Digit Verification of cas no

The CAS Registry Mumber 128540-39-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,5,4 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 128540-39:
(8*1)+(7*2)+(6*8)+(5*5)+(4*4)+(3*0)+(2*3)+(1*9)=126
126 % 10 = 6
So 128540-39-6 is a valid CAS Registry Number.

128540-39-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name [4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]methanamine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:128540-39-6 SDS

128540-39-6Relevant articles and documents

Synthesis, gastrointestinal prokinetic activity and structure-activity relationships of novel N-[[2-(dialkylamino)ethoxy]benzyl]benzamide derivatives

Sakaguchi,Nishino,Ogawa,Iwanaga,Yasuda,Kato,Ito

, p. 202 - 211 (2007/10/02)

Novel N-[[2-(dialkylamino)ethoxy]benzyl]benzamide derivatives (II-1-51), derived from the structural modification of metoclopramide (1), were synthesized and examined for their pharmacological activities. Among them, N-[4-[2-(dimethylamino)ethoxy]benzyl]-3,4-dimethoxybenzamide (II-34) which exhibited well balanced gastrointestinal prokinetic and antiemetic activities was selected as a new type of gastrointestinal prokinetic agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 128540-39-6